Abstract:A multifunctional scaffold protein termed Disabled-2 (Dab2) has recently gained attention in the scientific community and has emerged as a promising candidate in the realm of cancer research. Dab2 protein is involved in a variety of signaling pathways, due to which its significance in the pathogenesis of several carcinomas has drawn considerable attention. Dab2 is essential for controlling the advancement of cancer because it engages in essential signaling pathways such as the Wnt/β-catenin, epidermal growth factor receptor (EGFR), and transforming growth factor-beta (TGF-β) pathways. Dab2 can also repress epithelial-mesenchymal transition (EMT) which is involved in tumor progression with metastatic expansion and adds another layer of significance to its possible impact on cancer spread. Furthermore, the role of Dab2 in processes such as cell growth, differentiation, apoptosis, invasion, and metastasis has been explored in certain investigative studies suggesting its significance. The present review examines the role of Dab2 in the pathogenesis of various cancer subtypes including breast cancer, ovarian cancer, gastric cancer, prostate cancer, and bladder urothelial carcinoma and also sheds some light on its potential to act as a therapeutic target and a prognostic marker in the treatment of various carcinomas. By deciphering this protein’s diverse signaling, we hope to provide useful insights that may pave the way for novel therapeutic techniques and tailored treatment approaches in cancer management. Preclinical and clinical trial data on the impact of Dab2 regulation in cancer have also been included, allowing us to delineate role of Dab2 in tumor suppressor function, as well as its correlation with disease stage classification and potential therapy options. However, we observed that there is very scarce data in the form of studies on the evaluation of Dab2 role and treatment function in carcinomas, and further research into this matter could prove beneficial in the generation of novel therapeutic agents for patient-centric and tailored therapy, as well as early prognosis of carcinomas.

The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression

Disable 2, A Versatile Tissue Matrix Multifunctional Scaffold Protein with Multifaceted Signaling: Unveiling Role in Breast Cancer for Therapeutic Revolution

Disabled-2, a versatile tissue matrix multifunctional scaffold protein with multifaceted signaling: Unveiling its potential in the cancer battle

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis

DAB2IP Coordinates Both PI3K-Akt and ASK1 Pathways for Cell Survival and Apoptosis

Disabled 2 (Dab2) Regulates Tumour Progression in Skin Squamous Cell Carcinoma

The role of disabled-2 (Dab2) in diseases

Tumor-Promoting ATAD2 and Its Preclinical Challenges

The role of DAPK2 as a key regulatory element in various human cancers: a systematic review

Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer

An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications

DDB2 regulates Epithelial-to-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell Carcinoma

High expression of disabled homolog 2-interacting protein contributes to tumor development and proliferation in cutaneous squamous cell carcinoma

DAB2IP suppresses invadopodia formation through destabilizing ALK by interacting with USP10 in breast cancer

Dab2 (Disabled-2), an adaptor protein, regulates self-renewal of hair follicle stem cells

DDR1 and DDR2: a review on signaling pathway and small molecule inhibitors as an anticancer agent

TFCP2 as a therapeutic nexus: unveiling molecular signatures in cancer

Downregulation Of Human Dab2ip Gene Expression In Prostate Cancer Cells Results In Resistance To Ionizing Radiation

Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy.

Death-associated protein 3 in cancer—discrepant roles of DAP3 in tumours and molecular mechanisms

Mitotic phosphorylation of tumor suppressor DAB2IP maintains spindle assembly checkpoint and chromosomal stability through activating PLK1-Mps1 signal pathway and stabilizing mitotic checkpoint complex